Who owns Oramed Pharm?
- Ticker: ORMP
- CUSIP Number: 68403P203
Tip: Access positions for across all investors
Analyze quarterly positions in Oramed Pharm with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Oramed Pharm stock
Who bought or sold Oramed Pharm this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BML Capital Management | 3.2M | $8.4M | 3% | Sep 2025 |
|
| Murchinson | 1.8M | $4.6M | 0% | Sep 2025 |
|
| Boothbay Fund Management | 845k | $2.2M | 0% | Sep 2025 |
|
| Rathbones Brothers | 233k | $615k | 0% | Sep 2025 |
|
| Renaissance Technologies | 149k | $393k | 3% | Sep 2025 |
|
| Dimensional Fund Advisors | 148k | $389k | -12% | Sep 2025 |
|
| Wells Fargo & Company | 130k | $343k | 520% | Sep 2025 |
|
| Citadel Advisors | 112k | $295k | 1% | Sep 2025 |
|
| BlackRock | 110k | $290k | 28% | Sep 2025 |
|
| Jane Street | 60k | $158k | 41% | Sep 2025 |
|
| Rbf Capital | 43k | $113k | 0% | Sep 2025 |
|
| Susquehanna International | 37k | $97k | -49% | Sep 2025 |
|
| Morgan Stanley | 32k | $72k | 100% | Jun 2025 |
|
| Squarepoint Ops | 30k | $79k | -35% | Sep 2025 |
|
| Connor, Clark & Lunn Investment Management | 28k | $75k | -53% | Sep 2025 |
|
| Geode Capital Management | 24k | $64k | 0% | Sep 2025 |
|
| XTX Topco | 24k | $63k | 100% | Sep 2025 |
|
| Pnc Financial Services | 23k | $61k | 0% | Sep 2025 |
|
| American Century Companies | 20k | $52k | 0% | Sep 2025 |
|
| Wealth Enhancement Advisory Services | 19k | $47k | 0% | Sep 2025 |
|
| Sage Capital Management | 17k | $44k | 0% | Sep 2025 |
|
| LPL Financial | 14k | $36k | -7% | Sep 2025 |
|
| Barclays | 13k | $35k | 0% | Sep 2025 |
|
| Close Asset Management | 12k | $31k | 0% | Sep 2025 |
|
| Altshuler Shaham | 11k | $30k | -5% | Sep 2025 |
|
| Mariner Wealth Advisors | 11k | $29k | 9% | Sep 2025 |
|
| Glass Jacobson Investment Advisors | 11k | $28k | 0% | Sep 2025 |
|
| Steward Partners Investment Advisory | 8.8k | $23k | 0% | Sep 2025 |
|
| Advisor Group Holdings | 4.3k | $9.5k | 0% | Sep 2025 |
|
| Royal Bank of Canada | 3.5k | $9.0k | -93% | Sep 2025 |
|
| Huntington National Bank | 3.0k | $7.9k | 0% | Sep 2025 |
|
| MAI Wealth Advisors | 2.1k | $5.4k | 0% | Sep 2025 |
|
| SBI Securities | 1.6k | $4.2k | -3% | Sep 2025 |
|
| Northwestern Mutual Wealth Management Company | 1.6k | $4.2k | 0% | Sep 2025 |
|
| McIlrath & Eck | 1.0k | $2.6k | 0% | Sep 2025 |
|
| Newbridge Financial Services Group | 1.0k | $2.6k | 0% | Sep 2025 |
|
| Jones Financial Companies, L.L | 714.00 | $1.7k | 43% | Sep 2025 |
|
| FMR | 500.00 | $1.3k | 100% | Sep 2025 |
|
| IFP Advisors | 500.00 | $1.3k | 0% | Sep 2025 |
|
| UBS Group | 357.00 | $945.014700 | -97% | Sep 2025 |
|
| Golden State Wealth Management | 303.00 | $800.010900 | 0% | Sep 2025 |
|
| Hanson McClain Advisors | 300.00 | $792.000000 | 0% | Sep 2025 |
|
| Hopwood Financial Services | 200.00 | $528.000000 | 0% | Sep 2025 |
|
| Jpmorgan Chase & Co | 170.00 | $449.089000 | 100% | Sep 2025 |
|
Who sold out of Oramed Pharm?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Peapod Lane Capital | Jun 2025 | 85k | $191k |
| State Street Corporation | Jun 2025 | 67k | $150k |
| Raymond James Financial | Jun 2025 | 3.6k | $8.0k |
| National Bank Of Canada /fi/ | Jun 2025 | 2.0k | $4.4k |
| FTB Advisors | Mar 2025 | 1.8k | $3.7k |
| Beacon Capital Management | Jun 2025 | 219.00 | $492.990900 |